Orthopediatrics Share Price (NASDAQ: KIDS)

$21.36

▲

-0.08

(-0.37%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Orthopediatrics Stock chart to analyse performance

Orthopediatrics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$21.22
Today's High:$21.43
$21.36
0.66%
Downside
Day's Volatility :0.98%
Upside
0.33%
52 Weeks Low:$16.59
52 Weeks High:$33.14
$21.36
22.33%
Downside
52 Weeks Volatility :49.94%
Upside
35.55%

Orthopediatrics Stock Returns

Period	Orthopediatrics Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	7.21%	3.6%	0.0%
6 Months	-7.56%	-7.7%	0.0%
1 Year	-29.84%	-12.6%	0.0%
3 Years	-56.08%	9.5%	-4.7%

Orthopediatrics Corp Key Stats

Check Orthopediatrics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$21.44
Open	$21.41
Today's High	$21.43
Today's Low	$21.22
Market Capitalization	$535.6M
Today's Volume	$89.6K
52 Week High	$33.14
52 Week Low	$16.59
Revenue TTM	$220.7M
EBITDA	$-13.3M
Earnings Per Share (EPS)	$-1.8
Profit Margin	-18.92%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-11.49%

Stock Returns calculator for Orthopediatrics Stock including INR - Dollar returns

The Orthopediatrics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Orthopediatrics investment value today

Current value as on today

₹72,139

Returns

₹27,861

(-27.86%)

Returns from Orthopediatrics Stock

₹33,146 (-33.15%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Orthopediatrics Stock

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Orthopediatrics Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Orthopediatrics Corp

Name
Holdings %
Name
Holdings %
Brown Advisory Holdings Inc
6.48%
Brown Capital Management, LLC
6.21%
BlackRock Inc
5.08%
BRAIDWELL LP
4.42%
Morgan Stanley - Brokerage Accounts
4.21%
Wellington Management Company LLP
4.10%

Analyst Recommendation on Orthopediatrics Stock

Rating

Trend

Buy

76%Buy

23%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Orthopediatrics(by analysts ranked 0 to 5 stars)

Orthopediatrics Share Price Target

What analysts predicted

Upside of 58.51%

Target:

$33.86

Current:

$21.36

Orthopediatrics share price target is $33.86, a slight Upside of 58.51% compared to current price of $21.36 as per analysts' prediction.

Orthopediatrics Stock Insights

Price Movement
In the last 7 days, KIDS stock has moved up by 5.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 52.41M → 61.08M (in $), with an average increase of 14.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -16.06M → -7.11M (in $), with an average increase of 50.3% per quarter
KIDS vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 62.0%
KIDS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 220.8%
Price to Sales
ForKIDS every $1 of sales, investors are willing to pay $2.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Orthopediatrics Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$72.6M	↑ 26.05%
Net Income	$-13.7M	↑ 14.19%
Net Profit Margin	-18.93%	↑ 1.96%

	FY20	Y/Y Change
Revenue	$71.1M	↓ 2.03%
Net Income	$-32.9M	↑ 139.92%
Net Profit Margin	-46.35%	↓ 27.42%

	FY21	Y/Y Change
Revenue	$98.0M	↑ 37.95%
Net Income	$-16.3M	↓ 50.64%
Net Profit Margin	-16.58%	↑ 29.77%

	FY22	Y/Y Change
Revenue	$122.3M	↑ 24.72%
Net Income	$1.3M	↓ 107.74%
Net Profit Margin	1.03%	↑ 17.61%

	FY23	Y/Y Change
Revenue	$148.7M	↑ 21.62%
Net Income	$-21.0M	↓ 1767.25%
Net Profit Margin	-14.1%	↓ 15.13%

	FY24	Y/Y Change
Revenue	$204.7M	↑ 37.65%
Net Income	$-37.8M	↑ 80.33%
Net Profit Margin	-18.47%	↓ 4.37%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$44.7M	↑ 18.8%
Net Income	$-7.8M	↑ 16.65%
Net Profit Margin	-17.47%	↑ 0.32%

	Q2 FY24	Q/Q Change
Revenue	$52.8M	↑ 18.16%
Net Income	$-6.0M	↓ 22.75%
Net Profit Margin	-11.42%	↑ 6.05%

	Q3 FY24	Q/Q Change
Revenue	$54.6M	↑ 3.35%
Net Income	$-7.9M	↑ 31.35%
Net Profit Margin	-14.51%	↓ 3.09%

	Q4 FY24	Q/Q Change
Revenue	$52.7M	↓ 3.49%
Net Income	$-16.1M	↑ 102.92%
Net Profit Margin	-30.51%	↓ 16.0%

	Q1 FY25	Q/Q Change
Revenue	$52.4M	↓ 0.49%
Net Income	$-10.7M	↓ 33.67%
Net Profit Margin	-20.34%	↑ 10.17%

	Q2 FY25	Q/Q Change
Revenue	$61.1M	↑ 16.54%
Net Income	$-7.1M	↓ 33.27%
Net Profit Margin	-11.65%	↑ 8.69%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$54.6M	↑ 27.97%

	FY20	Y/Y Change
Profit	$55.0M	↑ 0.75%

	FY21	Y/Y Change
Profit	$73.4M	↑ 33.38%

	FY22	Y/Y Change
Profit	$90.7M	↑ 23.51%

	FY23	Y/Y Change
Profit	$111.3M	↑ 22.71%

	FY24	Y/Y Change
Profit	$148.6M	↑ 33.57%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$27.1M	↑ 27.84%

	Q2 FY24	Q/Q Change
Profit	$36.0M	↑ 32.69%

	Q3 FY24	Q/Q Change
Profit	$40.1M	↑ 11.22%

	Q4 FY24	Q/Q Change
Profit	$35.6M	↓ 11.22%

	Q1 FY25	Q/Q Change
Profit	$38.3M	↑ 7.58%

	Q2 FY25	Q/Q Change
Profit	$44.0M	↑ 15.05%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-17.8M	↑ 14.03%
Investing Cash Flow	$-61.9M	↑ 938.09%
Financing Cash Flow	$91.0M	↑ 129.52%

	FY20	Y/Y Change
Operating Cash Flow	$-18.5M	↑ 4.28%
Investing Cash Flow	$-69.7M	↑ 12.55%
Financing Cash Flow	$46.7M	↓ 48.66%

	FY21	Y/Y Change
Operating Cash Flow	$-13.1M	↓ 29.5%
Investing Cash Flow	$-7.4M	↓ 89.37%
Financing Cash Flow	$6.0K	↓ 99.99%

	FY22	Y/Y Change
Operating Cash Flow	$-21.8M	↑ 66.62%
Investing Cash Flow	$-113.4M	↑ 1429.77%
Financing Cash Flow	$136.0M	↑ 2266133.33%

	FY23	Y/Y Change
Operating Cash Flow	$-27.0M	↑ 24.26%
Investing Cash Flow	$41.7M	↓ 136.76%
Financing Cash Flow	$7.3M	↓ 94.63%

	FY24	Y/Y Change
Operating Cash Flow	$-27.0M	↑ 0.01%
Investing Cash Flow	$-13.2M	↓ 131.58%
Financing Cash Flow	$53.1M	↑ 627.78%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.7M	↓ 11.31%
Investing Cash Flow	$-3.7M	↓ 120.53%
Financing Cash Flow	$-573.0K	↓ 106.1%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-6.4M	↓ 3.81%
Investing Cash Flow	$19.7M	↓ 635.39%
Financing Cash Flow	$-3.9M	↑ 585.17%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-10.3M	↑ 59.74%
Investing Cash Flow	$-26.8M	↓ 235.9%
Financing Cash Flow	$58.5M	↓ 1590.52%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.0M	↓ 61.21%
Investing Cash Flow	$-2.4M	↓ 90.99%
Financing Cash Flow	$-541.0K	↓ 100.92%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.2M	↑ 4.24%
Investing Cash Flow	$-6.0M	↑ 148.22%
Financing Cash Flow	$-126.0K	↓ 76.71%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-10.5M	↑ 151.73%
Investing Cash Flow	$-3.5M	↓ 40.79%
Financing Cash Flow	$24.8M	↓ 19782.54%

Orthopediatrics Technicals Summary

Sell

Neutral

Buy

Orthopediatrics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Orthopediatrics Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Orthopediatrics Corp	4.95%	-7.56%	-29.84%	-56.08%	-55.87%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Orthopediatrics Corp	246.27	NA	NA	-1.07	-0.11	-0.04	NA	14.18
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Orthopediatrics Corp	Buy	$535.6M	-55.87%	246.27	-18.92%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Orthopediatrics Corp

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Organization	Orthopediatrics
Employees	562
CEO	Mr. David R. Bailey
Industry	Health Technology

Key Management of Orthopediatrics Corp

Name	Title
Mr. Mark C. Throdahl	Executive Chairman
Mr. David R. Bailey	President, CEO & Director
Mr. Fred L. Hite	CFO, Principal Financial & Accounting Officer, COO and Director
Mr. Daniel J. Gerritzen J.D.	Executive VP of Legal, General Counsel & Secretary
Mr. Gregory A. Odle	President of Scoliosis
Mr. Joseph W. Hauser	President of Trauma, Deformity Correction & OPSB
Mr. Kevin L. Unger CHE, MBA/MSHA	President of Enabling Technologies
Mr. Mark Karshner	Senior Vice President of International Sales
Ray Garrison	Senior Vice President of Quality & Regulatory and Clinical

Important FAQs about investing in KIDS Stock from India :

What is Orthopediatrics share price today?

Orthopediatrics share price today is $21.36 as on August 30, 2025 at 1:29 am IST at the close of the market. Orthopediatrics share today touched a day high of $21.43 and a low of $21.22.

What is the 52 week high and 52 week low for Orthopediatrics share?

Orthopediatrics share touched a 52 week high of $33.14 and a 52 week low of $16.59. Orthopediatrics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $21.36, lower by 35.55% versus the 52 week high.

How to invest in Orthopediatrics Stock (KIDS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Orthopediatrics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Orthopediatrics Shares that will get you 0.0702 shares as per Orthopediatrics share price of $21.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Orthopediatrics Stock (KIDS) from India?

Indian investors can start investing in Orthopediatrics (KIDS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Orthopediatrics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Orthopediatrics share’s latest price of $21.36 as on August 30, 2025 at 1:29 am IST, you will get 0.4682 shares of Orthopediatrics. Learn more about fractional shares .

What are the returns that Orthopediatrics has given to Indian investors in the last 5 years?

Orthopediatrics stock has given -55.87% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?